The Effect of COVID-19 on Diabetes Mellitus

Last updated: May 1, 2021
Sponsor: Uşak University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Diabetes Prevention

Diabetes And Hypertension

Treatment

N/A

Clinical Study ID

NCT04592055
UU-DM002
  • Ages 18-80
  • All Genders

Study Summary

The study aimed to evaluate the effect of SARS-COV-2 infection on metabolic status in patients with diabetes mellitus. Patients' HbA1c levels before and after SARS-COV-2 infection will be evaluated.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • All hospitalised diabetic patients with RT-PCR- positive for SARS-COV-2 will be enrolled.

Exclusion

Exclusion Criteria:

  • The absence of diabetes mellitus RT-PCR- negative for SARS-COV-2 Non-hospitalisedpatients

Study Design

Total Participants: 500
Study Start date:
March 20, 2020
Estimated Completion Date:
July 01, 2021

Study Description

In this time pediods, all patients with RT-PCR positive for SARS-COV-2 will be analysed for the presence of diabetes mellitus. Previous HbA1c levels will be obtained from hospital records. In these patients, previous A1c levels and A1c levels 3 months after the SARS-COV-2 infection will be compared.

Connect with a study center

  • Usak University Training and Research Hospital

    Usak, 64200
    Turkey

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.